In an update on the implementation of the new Clinical Trials Regulation, the MHRA expresses increased confidence that the UK will exit the EU with a deal – and reaffirms its commitment to align with parts of the legislation “within the UK’s control.”
ABL Bio and I-Mab Biopharma ink bispecific antibody deal
from BioPharma-Reporter.com
US FDA grants Apotex industry-first approval, day after delivers warning letter
from in-PharmaTechnologist.com
Regulatory eyes on Regeneron: US FDA issues CRL for Eylea
from BioPharma-Reporter.com
US FDA approves first non-gene edited allogeneic CAR T-cell candidate for trials
from BioPharma-Reporter.com
Robotics, automation to play a ‘fundamental role’ in Icon’s continued success: Q2 earnings call
Clinical evolution
Jerusalem’s Hadassah Medical Center joins TriNetX network
Globalization
PSI CRO continues growth in Asia-Pacific
Globalization
EMA pulls back on activity, with 30%+ staff losses expected
Globalization
